A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

NCT04974866 ·Status: RECRUITING ·Phase: PHASE2

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NCT04814056 ·Status: UNKNOWN ·Phase: PHASE4

Primary Tumor Resection With EGFR TKI for Stage IV NSCLC

NCT05215548 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

NCT01358084 ·Status: COMPLETED ·Phase: PHASE2

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04501497 ·Status: COMPLETED

Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations

NCT04811001 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma

NCT04201756 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00388063 ·Status: COMPLETED ·Phase: PHASE2

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

NCT02108964 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC

NCT02250846 ·Status: UNKNOWN ·Phase: PHASE2

Phase 2 Study of Dacomitinib in NSCLC

NCT04027647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

ATOM_local Ablative Therapy

NCT01941654 ·Status: COMPLETED ·Phase: PHASE2

HS-IT101 Injection for Advanced NSCLC

NCT07105176 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response

NCT01167244 ·Status: COMPLETED ·Phase: PHASE2

Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF)

NCT06219733 ·Status: WITHDRAWN ·Phase: PHASE2

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

NCT05552781 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations

NCT06940401 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Afatinib in Advanced NRG1-Rearranged Malignancies

NCT04410653 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

NCT07318649 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

NCT03645330 ·Status: COMPLETED

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03563716 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

NCT01470716 ·Status: UNKNOWN ·Phase: PHASE2

A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation

NCT04204473 ·Status: COMPLETED ·Phase: PHASE1

A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC).

NCT05141786 ·Status: UNKNOWN ·Phase: PHASE2

Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma

NCT00663429 ·Status: COMPLETED ·Phase: PHASE2